Cargando...
Ustekinumab in Crohn’s disease: evidence to date and place in therapy
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) with uncertain etiology. Biologic agents have revolutionized the treatment of CD but nonresponders remain a challenge. Ustekinumab is an interleukin 12/23p40 inhibitor that was recently found effective in treating CD. We reviewed the curren...
Gardado en:
| Publicado en: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935835/ https://ncbi.nlm.nih.gov/pubmed/27433311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316653306 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|